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Abstract
Animal models continue to improve our understanding of tinnitus pathogenesis and aid in development of new treatments.
However, there are no diagnostic biomarkers for tinnitus-related pathophysiology for use in awake, freely moving animals.
To address this disparity, two complementary methods were combined to examine reliable tinnitus models (rats repeatedly
administered salicylate or exposed to a single noise event): inhibition of acoustic startle and manganese-enhanced MRI.
Salicylate-induced tinnitus resulted in wide spread supernormal manganese uptake compared to noise-induced tinnitus.
Neither model demonstrated significant differences in the auditory cortex. Only in the dorsal cortex of the inferior colliculus
(DCIC) did both models exhibit supernormal uptake. Therefore, abnormal membrane depolarization in the DCIC appears to
be important in tinnitus-mediated activity. Our results provide the foundation for future studies correlating the severity and
longevity of tinnitus with hearing loss and neuronal activity in specific brain regions and tools for evaluating treatment
efficacy across paradigms.
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Introduction
Tinnitus, the perception of a ringing, buzzing, or hissing in the
absence of an external stimulus due to noise, drugs, or traumatic
brain injury, is a rapidly growing major health concern affecting
both civilian and military populations [1,2,3,4]. Mounting
evidence suggests that tinnitus can be linked with increased
spontaneous neuronal activity [5,6,7,8] leading to the use of drugs
targeted at reducing spikes of increased activity. However, such
approaches have only been partially successful [5,9,10,11,12]. A
better understanding of the pathophysiology of tinnitus is needed
to improve future treatment efforts.
Animal models of tinnitus (e.g., noise or drug induced) produce
increases in spontaneous neuronal activity, which are likely
downstream consequences of changes in calcium and calcium
channel-dependent neurotransmitter release. Blocking calcium
channels with nimodipine has been shown to reduce percepts
associated with salicylate-induced tinnitus [13,14,15,16]. Despite
such promising results, there is a pressing need to analytically
measure calcium ion regulation in auditory-related brain regions
to determine whether or not common brain regions and
abnormalities exist across tinnitus models.
A recent methodological advance in the tinnitus field involves
the use of gap and pre-pulse inhibition of the acoustic startle reflex
(ASR) for screening of tinnitus percepts in animal models. The
paradigm was designed to assess whether the subject perceives
tinnitus by introducing a pre-stimulus ‘‘gap’’ in sound (silence) just
prior to the startle stimulus. If the pre-stimulus gap is detected,
there is a decreased startle reflex observed when the startle
stimulus is presented (Figure 1A–B). If the gap is embedded in a
tone that closely matches the animal’s tinnitus in frequency and
intensity, the result is a full startle reflex that is not blunted [17].
While such psychophysical tests are useful in the assessment of
tinnitus percepts, they cannot spatially resolve pathological
changes in specific auditory regions and so miss important
mechanistic information regarding the initiation and maintenance
of tinnitus.
Manganese-enhanced MRI (MEMRI) with systemically admin-
istered MnCl2 has been used to examine neuronal activity in vivo
[18,19,20]. The paramagnetic Mn
2+ ion (manganese) can enter
active neurons through voltage-gated calcium channels, amongst
others calcium channels [21,22,23,24,25]. Since manganese efflux
from cells is slow [26], activity-dependent accumulation of the ion
in brain regions can be measured as a decrease in tissue T1 at high
spatial resolution hours later [27,28,29]. In this manner, MEMRI
has been used to measure sound-evoked activity in the midbrain
from awake and free moving rodents [20,30]. To-date only one
study has used MEMRI to investigate tinnitus, however, analysis
was performed in excised tissue [18]. Whether manganese
accumulation in auditory-related brain regions will be sensitive
enough to detect differences between awake and freely moving
animals with and without tinnitus or between groups with tinnitus
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remains to be determined.
In this study, behavioral (ASR) and imaging (MEMRI)
assessments were combined to identify and characterize early
stages of tinnitus in two different animal models. We have
identified a common brain region with increased activity
regardless of the method of tinnitus induction, and brain regions
in which activation is specific to the method used to induce the
tinnitus.
Results
Salicylate and noise exposure result in temporal
differences in hearing loss
Relative to that in controls (average of 30 dB across three
frequencies), injection of salicylate results in significant changes in
hearing thresholds (32 dB; p=0.04) when animals were tested two
hours following administration on the second day of treatment
(Table 1). After 10 hours with no additional salicylate hearing
thresholds returned to normal (Table 2). Therefore, daily
administration of salicylate resulted in daily temporary threshold
shifts averaging 1–12 dB across frequencies depending upon the
time after salicylate administration. In contrast, animals that were
exposed to a 10 kHz 118 dB 1/3 octave band noise generally
exhibited profound deafness (Table 1) with average thresholds of
98 dB or more in the ear that was not plugged (p=6.0 E
26) and
elevated thresholds averaging of 51 dB across the three frequen-
cies, tested in the plugged ear, that were not significantly different
from control thresholds (p=0.09). Two animals that were noise
exposed, but were not imaged had ABR assessment at both 24 and
48 hours with animals tested at 48 hours showing no significant
change in hearing thresholds from the 24 hour time point (data
not shown). Therefore, in contrast to salicylate-induced changes in
hearing threshold, we found no evidence for diminished noise-
induced changes in this study. Therefore, changes in hearing, as
measured by ABR, were temporary for salicylate-injected animals
and permanent (bilaterally, although asymmetrical) for sound
exposed animals (Tables 1 and 2). To determine whether these
temporal differences in hearing loss would differentially affect
tinnitus percepts we recorded pASR and gASR across both animal
models of tinnitus and normal hearing controls.
ASR demonstrates specific tinnitus percepts specific to
the animal model
To compare behavioral correlates of salicylate and noise
induced tinnitus, the acoustic startle reflex was tested and
compared at three time points per group, before salicylate
treatment or noise exposure (baseline 2–3 measures), after
salicylate administration (after one hour on day two) or noise
treatment (after 24 hours) as well as on the day of imaging seven
hours after the final administration of salicylate or 55 hours
following noise (Figure 2).
For ASR testing animals needed to demonstrate the ability to
exhibit a robust startle reflex in response to a brief loud noise as
well as the capacity to attenuate the startle reflex in the presence of
a pre-pulse or a silent gap in a tone. Of the animals tested for
startle reflex under baseline conditions, all of the animals exhibited
both a robust sound off startle reflex as well as the ability to inhibit
the reflex in approximately 70% of the 120 total trials - - ten trials
recorded for each of the six different frequencies tested at two
different sound levels (45 and 60 dB for control and salicylate
groups, 70 and 95 dB for the noise exposed group).
Control animals showed a robust attenuation of both the pASR
and the gASR regardless of the frequency that was tested
(Figure 3). However, inhibition of the acoustic startle reflex was
less variable at 60 dB when compared to 45 dB (data not shown)
suggesting that the higher intensity pre-pulse or background tones
increased ASR sensitivity when comparing performance across
frequencies. Therefore results are presented for the 60 dB levels.
In pre-drug baseline testing, rats in the salicylate group detected
either the prepulse (Figure 3A) or the gap (Figure 3B) and
demonstrated the ability to suppress the startle reflex. Across
frequencies, pASR testing revealed robust suppression of the
Figure 1. Schematic of acoustic startle reflex (ASR) under conditions of pre-pulse (pASR) or gap (gASR) inhibition. (A) During the
pASR test animals are presented with a randomly introduced 120 dB stimulus resulting in a measurable startle response. If a 50 ms tone preceding a
50 ms silent period is introduced and detected just prior to the startle stimulus, usually a decreased startle reflex is observed. (B) When a startle
stimulus is presented in the presence of a continuous background tone (4,8,12, 16, 20, or 24 kHz) a startle reflex is elicited. If a 50 ms silent gap in the
background tone is presented just prior to the startle stimulus then the startle response is decreased. However, if an animal has tinnitus percepts and
the tone matches the tinnitus in frequency and loudness then the silent gap is filled in by the animal’s tinnitus and the startle response is not
significantly blunted.
doi:10.1371/journal.pone.0014260.g001
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sion was observed one hour after salicylate treatment on the
second day (69.5%61.50; p,0.0001), and seven hours after
salicylate treatment on the third day (59%62.34; p,0.0001;
Figure 3A). Relative to the full startle response amplitude (100%)
gASR testing at 12 kHz (Figure 3B) resulted in a robust
attenuation of startle (26%62.92). After salicylate treatment,
gASR startle amplitude was significantly increased at 12 kHz
(12%63.85; p=0.05) over baseline, but was not significantly
different from baseline 7 hours post treatment (Figure 3B). In
addition, salicylate treated animals exerted significantly more force
in response to the startle stimulus only when compared to controls
both during pASR (Figure 4A) testing (0.9060.08; p,0.0001 1 hr
after injection; 0.9360.14; p,0.0001 seven hrs after injection) and
gASR (Figure 4B) testing (0.2260.04; p=0.02 1 hr after injection;
0.2560.03; p#0.05 seven hrs after injection). Thus, gASR testing
demonstrated cyclical salicylate-induced tinnitus as shown by ABR
(Table 2), while pASR testing demonstrated a more sustained
hyperacusis (Figure 3A) with both tests reflecting increased force
following treatment when comparing force exerted in response to
startle stimulation only (Figure 4).
Just as with the control and the salicylate groups, the baseline
measures in the noise group indicated the ability of the animals to
reliably inhibit pASR and gASR (Figure 5). Following exposure to
a 10 kHz 118 dB 1/3 octave band sound animals sustained a
substantive threshold shift (Table 1). Therefore the intensities for
the pre-pulse (pASR) and background tones (gASR) were
increased to levels that could be detected by the animals (70 and
95 dB). Despite the noise exposure, animals attenuated pASR
responses across all frequencies at each time point tested (baseline
– 30%, 24 hrs – 20%, 55 hrs – 24%) confirming that the animals
were able to hear the pre-pulse (Figure 5A) with the decrease from
30% to 20 and 24% suggesting hearing loss effects. When tested
for inhibition of gASR, there was a significant reduction in the
ability to inhibit the acoustic startle reflex at both post-noise time
points at the frequencies of 12 (baseline – 28%, 24 hrs – 16%
p=0.0079, 55 hrs – 14% p=.0008) and 16 kHz (baseline – 33%,
24 hrs – 21% p=0.0079, 55 hrs – 17% p=0.0003), reflecting the
capacity of gASR to demonstrate not only the hearing loss but the
perception of tinnitus as well. The results suggest that the tinnitus
percepts were fairly tonal in nature and were experienced across
two (12 kHz and 16 kHz) of the tested frequencies (Figure 5B–C).
In animals that were not exposed to salicylate or noise, (the
control group), the ability to inhibit the gASR remained constant
(Figure 6). However, the salicylate group showed a decreased
ability to inhibit gASR one hour after salicylate treatment, but by
seven hours the ability to attenuate gASR had returned to normal
levels. For noise-exposed animals, the ability to inhibit the gASR
remained decreased at both time points following noise exposure
(Figure 6). These results further support the idea that the tinnitus
experienced by the salicylate group was transient while the noise-
exposed group experienced a more uninterrupted tinnitus.
MEMRI measures tinnitus-dependent differential regional
brain activity
Salicylate and noise groups were given manganese 8 hours prior
to imaging. This corresponded to a time when animals exhibited
behavioral correlates of tinnitus (ASR testing of salicylate and
noise groups).
Allmanganese-injectedanimalsexhibited theexpectedhighsignal
intensities inthe anteriorpituitary[31].Rawsignalintensities(before
normalization to muscle) were analyzed at this location to verify that
control and tinnitus groups experienced similar brain systemic
manganese exposure: Between groups, raw signal intensities were
similar at the anterior pituitary and adjacent muscle alike (one-way
ANOVAs, P.0.05). These raw intensities were correlated (r=0.49;
P=0.016), indicating that normalization to muscle would reduce
inter-subject variability in brain signal intensities. After normaliza-
tion to adjacent muscle, no group differences were found at the
anterior pituitary (one-way ANOVA, P.0.05).
In non-auditory regions (listed in Table 3), no significant group
differences in manganese uptake were found (one-way ANOVAs,
P.0.05). For completeness, mean normalized signal intensities for
Table 1. Summary of hearing thresholds following salicylate or noise treatment: Auditory brainstem responses.
Frequency 4 kHz 12 kHz 20 kHz Average P-value a
Treatment Left Right Left Right Left Right Left Right
Control
b, c 3165.74 2963.85 2962.49 2862.40 3064.77 3063.30 3064.33 2963.18 -
Salicylate
b, c 3062.50 3363.50 3263.95 3262.38 3163.11 3262.22 3163.01 3262.62 0.05
Noise I
b, c 33±6.85 9669.00 65±22.81 100q 62±19.25 100q 53±21.80 9965.20 Noise-Plugged 0.16
Noise-Unplugged 0.004
Noise II
b, c 90614.14 30±2.12 100q 58±14.14 100q 51±24.04 9768.16 46±18.25 Noise-Plugged 0.19
Noise-Unplugged 0.001
aSignificance p#0.05.
bHearing threshold, expressed in decibels (dB).
cError (6) is expressed as SEM.
100qMore than 100 dB.
Bold indicates the protected (plugged) ear (Noise I left ear protected Noise II had the right ear protected).
doi:10.1371/journal.pone.0014260.t001
Table 2. Hearing thresholds at two time points following
salicylate administration: Auditory brainstem responses.
Frequency 4 kHz 12 kHz 20 kHz
Treatment
Control
a,b 3065.04 2862.45 3064.15
6 hrs after injection
a,b 3462.99 3462.50 3362.89
10 hrs after injection
a,b 3062.22 3061.73 3061.50
aHearing threshold, expressed in decibels (dB).
bError (6) is expressed as SEM.
doi:10.1371/journal.pone.0014260.t002
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perception, auditory brainstem response testing (ABR) for hearing loss, tinnitus induction, manganese injection and imaging in control (A), salicylate
(B) and noise (C) groups during a given day. 8 – first eight hrs of day, 16 – second eight hr period of day, 24 – last eight hr period of day, SA –
salicylate injection, NE – noise exposure, Mn
2+ - manganese injection, MRI – magnetic resonance imaging.
doi:10.1371/journal.pone.0014260.g002
Figure 3. Salicylate results in a decreased ability to blunt the acoustic startle response (ASR) under conditions of gap inhibition.
Performance during ASR testing was recorded before treatment (Baseline), 1 hr following the second day of salicylate administration (Post Treatment
1) and seven hrs following the third day of salicylate administration (Post Treatment 2). Relative to a full startle response (100%), untreated rats
detected the gap and prepulse and could suppress the startle reflex across all frequencies (baseline in A). Across all frequencies significant decreases
in pASR were observed relative to baseline both one hour following salicylate administration (Post Treatment 1) and seven hours after treatment
(Post Treatment 2) (A). When compared to baseline, p=0.0001 for both Post Treatment 1 and 2 (compare a–b and a–c). Post Treatment 1 and 2 were
also significantly different from one another (b–c; p=0.0004). At 12 kHz the % sound off startle initially changed by 12% (p=0.05) from Baseline to
Post Treatment 1, but was not significantly different from Baseline during Post Treatment 2 testing (B). Differing letters denote significance across
time points, p#0.05 was significant; error bars equal SEM.
doi:10.1371/journal.pone.0014260.g003
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PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e14260Figure 4. Treatment with salicylate or noise results in changes in startle force elicited by the startle stimulus. There was no significant
difference in Baseline acoustic startle response (ASR) values during Prepulse (A) or Gap (B) tests when comparing control, salicylate and noise groups.
Follwing salicylate treatment there were significant differences in startle force when compared to controls during prepulse testing for both Post
Treatment 1 and Post Treatment 2 (p#0.0001 in each case) as well as gap testing (Post Treatment 2 p=0.002). For the noise treated group there no
significant differences in startle force when compared to controls during prepulse testing for Post Treatment 1 or Post Treatment 2 (p=0.093) nor
gap testing for Post Treatment 1 or 2 (p=.09). p#0.05 was significant; error bars equal SEM.
doi:10.1371/journal.pone.0014260.g004
Figure 5. Hearing loss (pre-pulse) and tinnitus (Gap) perception following exposure to loud noise. A decreased ability to blunt the
acoustic startle response (ASR) occurred under conditions prepulse inhibition (A), but was more pronounced during gap inhibition testing (B,C).
Performance during ASR testing was recorded before noise exposure (Baseline), on the second day following noise exposure (Post Treatment 1) and
on the third day following noise exposure (Post Treatment 2). (A) Relative to a full startle response (100%) animals were able to suppress the ASR by
30% during prepulse detection trials (baseline). (B) However, during post treatment 1 testing, at 12 kHz suppression was only 16% and by 48 hrs
(post treatment 2) only 13%. (C) Also, at 16 kHz baseline gASR was 33% but by 24 hrs after noise exposure (post treatment 1) was only 21% of
baseline and after 48 hrs (post treatment 2) 17% of baseline). Differing letters denote significance across time points, p#0.05 was considered
significant; error bars equal SEM.
doi:10.1371/journal.pone.0014260.g005
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controlgroup to each experimentalgroup, arepresented inTable 3.
Layer-specific analysis of the cortex revealed no group differences
(P.0.05 for all cortical depths tested in all regions). Normalized
signal intensities, averaged over cortical depths corresponding to
layers II through VI, are similarly provided in Table 3.
Significant group differences were found in the DCN
(Figure 7A–B; F[2,17]=5.22; P=0.017) and the DCIC
(Figure 8A–B; F[2,17]=7.60; P=0.004). In post-hoc testing (two-
tailed t-tests, uncorrected p-values reported), DCN manganese
uptake was similar in noise-exposed and control groups (P.0.05),
but elevated in the salicylate-exposed group (vs. noise P=0.033;
vs. control, P=0.023; Figure 7A–B). In contrast, DCIC manga-
nese uptake was elevated in animals with tinnitus (control vs. noise,
P=0.025; control vs. salicylate, P=0.005); and there was no
significant difference between salicylate- and noise-exposed groups
(P.0.05; Figure 8A–B;). Statistical conclusions were identical
when Tukey’s Honestly Significant Difference test was used for
post-hoc analysis (data not shown).
Besides the DCIC and DCN, no group differences in
manganese uptake were found for any other sub-cortical structures
(Figure 7–8 and Table 3). Sub-divisions of the inferior colliculus
besides the DCIC (i.e. the ECIC and CNIC) failed to reach
statistical significance (Figure 8), we found no evidence for group-
wise regional differences within the inferior colliculus: Tests for
both the ECIC and CNIC regions reached marginal significance
(for each region, F[2,17].2.73; P,0.10), and showed a similar
between-group pattern of manganese uptake (Figure 8 i.e.
control,salicylate; noise<salicylate). In each group, normalized
signal intensities trended lower in the ECIC and CNIC than in the
DCIC (Table 3), though only for the CNIC was this difference
significant in all three groups (paired two-tailed t-tests, P,0.002
for each). In control animals, VCN signal intensities were greater
than in the DCIC, though still lower than in the DCN (paired two-
tailed t-tests; p=0.009 and 0.001 respectively, Table 3).
The pattern of regional signal intensities seen in the auditory
regions of control animals (DCN.VCN.DCIC.CNIC.Aud) is
intriguing. However, several factors unrelated to baseline neuronal
activity may complicate between-region comparisons of MEMRI
data (e.g. differences in myelination, proximity to ventricular space).
Discussion
The literature suggests anomalous neural activity within central
auditory pathways associated with tinnitus inducing drugs and
noise [32,33,34,35]. However, this is the first study in which all
subjects undergoing tinnitus assessment also underwent imaging
analysis in vivo. Using this approach we found that both salicylate
and noise-induced tinnitus result in increased neuronal activity in
DCIC neurons. The IC is the point of integration of all ascending
and descending projections to the auditory cortex with the DCIC
receiving the largest portion of the descending fibers
[36,37,38,39,40,41,42]. The DCIC receives ascending projections
from the DCN, the anteroventral cochlear nucleus (AVCN) and
the dorsal nucleus of the lateral lemniscus (DNLL). Significant
changes in activity were not observed in MGN or the auditory
cortex. Future work may detect a spread of increased neuronal
activity to those regions over time.
ASR characterization of tinnitus percepts
First, we evaluated the tinnitus status of each rat. Using inhibition
of startle techniques, pASR and gASR, we were able to correlate a
decrease in the ability to inhibit the ASR at specific frequencies with
the perception of tinnitus. These data support and extend previous
results using this technique to characterize tinnitus.
ASR inhibition discriminates fluctuations in salicylate
induced tinnitus. In the salicylate group, relative to a full
startle response, all animals exhibited the ability to inhibit their
ASR prior to treatment. One hour following salicylate
administration, ASR suppression was diminished, though only
for pre-startle tones centered on a frequency of 12 kHz (11–
13 kHz). These results closely match previous studies, which
identify salicylate-induced tinnitus with percepts ranging from
,10–16 kHz [43,44,45,46,47,48,49]. Six hours after the last
Figure 6. Summary graph of gap ASR comparing experimental groups (control, salicylate, noise) at three different time points
(baseline, post treatment 1 and post treatment 2). For control animals the percent inhibition of startle remains constant. For the salicylate
group post treatment 1 testing resulted in decreased inhibition of gASR, but by post treatment 2 testing, gASR had returned to normal levels. The
10 kHz noise group demonstrated a decreased ability to inhibit gASR at both time points following noise exposure when compared to baseline. Error
bars equal SEM.
doi:10.1371/journal.pone.0014260.g006
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from baseline, likely reflecting the decrease in systemic salicylate
and therefore decreased tinnitus perception. These results are
consistent with those of other studies demonstrating that salicylate
induced tinnitus in the rat is stable in terms of hearing loss and
tinnitus perception by the third day of treatment and that the
perception of tinnitus is reversible [43,44,45,46,47,48,49].
ASR inhibition suggests salicylate induced tinnitus results
inhyperacusis. Wealsotested theperformanceofthe animalsin
pASR testing. We typically use pASR to verify that animals can
detect tones and thus negate hearing loss as a factor on
performance. Prior to treatment animals were able to inhibit their
ASR in response to a pre-pulse. Following salicylate treatment the
inhibition was more robust. Previous studies as well as the current
study have noted a general increase in startle amplitude for animals
administered salicylate [49,50,51]. Because each startle event is
compared to the full startle response from each session, the ability to
suppress the startle response following salicylate administration
would be expected to diminish. This was not the case in the present
work, suggesting an improvement in auditory perception leading to
a heightened suppression of the startle response that has been
termed ‘‘hyperacusis’’. This type of sensitivity to loud noise is often
observed in human subjects with tinnitus.
ASR inhibition differentiates frequency specific changes
in noise-induced tinnitus. In animal models, noise has also
been used to induce tinnitus, as defined via behavioral testing,
[17,52,53]. In addition to the current study, other reports
demonstrate that exposure to the equivalent of a 10 kHz 118 dB
1/3 octave band tone results in tinnitus, but also profound
deafness [54]. Since the ASR performance is dependent upon
hearing, in the current study one ear in each animal from the noise
group was plugged during the noise exposure, leaving that ear
capable of detecting the tones for pASR and gASR in addition to
resulting in an asymmetric hearing loss. The fact that only one
functional ear is necessary for pASR and gASR tinnitus assessment
has previously been reported [17]. To compensate for increased
hearing thresholds in the plugged ear, intensity levels were raised
for ASR testing. To determine whether the animals had the ability
to hear well enough to inhibit the ASR, we first tested pASR.
Animals were able to consistently decrease their startle amplitude
from the full startle response (i.e. 100%). Next, performance on the
gASR test was assessed and both 12 kHz and 16 kHz showed
evidence of tinnitus-like percepts at both time points (24 and 48)
hours following noise exposure.
Thus, a total of two ASR sessions were recorded following
treatment with either salicylate or noise. The second post
treatment ASR test was given 54 to 56 hours following the initial
induction of tinnitus. For the salicylate group this time point
corresponded with seven hours following the day three salicylate
injection (post treatment 2 ASR) and results from gASR testing
showed no significant difference between the post treatment 2
gASR (7 hours following the day three salicylate injection) and
baseline measures perhaps indicating a lack or decrease of tinnitus
percepts. These results support previous findings showing the
diminution of tinnitus percepts within four–six hours following
salicylate administration [51]. For the noise group, frequencies
associated with tinnitus percepts post-treatment, continued to
exhibit gASR measures significantly different from baseline
measures even on the second day of assessment following
exposure. Our results confirm findings from previous studies
showing that gASR is an advantageous and reliable technique for
assessment of tinnitus whether induced by salicylate [30] or noise
[17,51]. Given our ASR results in both the salicylate and noise
groups we concluded that the animals experienced tinnitus-like
percepts. However, ASR tests do not provide insight into specific
tinnitus-related brain pathophysiology such as altered regulation of
ions (i.e., calcium).
Table 3. Effects of salicylate and noise exposure on neuronal
activity in different brain regions as measured by manganese
enhanced MRI.
Tinnitus Group Control
bcd Salicylate
bcd Noise
bcd
Brain Region
Amyg
a mean 160.864.0 158.766.8 169.766.6
p-value 0.77 0.23
Au1
a mean 149.961.8 145.264.7 151.964.6
p-value 0.39 0.69
AuD mean 148.762.1 144.764.8 152.565.2
p-value 0.46 0.52
DCN
a mean 210.366.8 242.4612.1 209.965.2
p-value 0.02 0.96
VCN mean 189.065.6 189.5 63.9 187.469.0
p-value 0.94 0.79
VCPO mean 195.867.4 190.963.5 198.864.5
p-value 0.55 0.73
Floc
a mean 172.065.2 168.361.9 169.163.4
p-value 0.52 0.64
Pfloc mean 162.764.1 158.062.1 158.063.1
p-value 0.43 0.38
LGN
a mean 152.263.0 154.664.9 164.566.0
p-value 0.94 0.79
MGN mean 167.364.7 170.463.5 170.965.0
p-value 0.59 0.59
CNIC
a mean 163.163.4 174.263.6 170.964.2
p-value 0.03 0.15
DCIC mean 176.763.2 195.265.0 186.462.2
p-value 0.01 0.03
ECIC mean 175.763.5 186.562.3 181.663.9
p-value 0.02 0.25
SC mean 162.964.7 169.864.4 169.864.8
p-value 0.28 0.34
TeA
a mean 156.262.2 153.464.2 154.762.8
p-value 0.58 0.69
V1 mean 148.262.5 147.063.7 154.564.3
p-value 0.80 0.24
V1B mean 150.063.4 156.063.3 157.362.7
p-value 0.23 0.12
V1M mean 147.263.4 154.863.8 157.963.1
p-value 0.17 0.04
V2L mean 154.962.7 155.863.1 153.563.2
p-value 0.73 0.84
V2MM & V2ML mean 145.962.6 149.064.3 154.064.1
p-value 0.44 0.12
aBold text indicates beginning of new brain region.
bSignal intensity, expressed as the percentage of adjacent muscle; arbitrary
units (a.u.).
cSignificance p#0.05.
dError (6) is expressed as SEM.
doi:10.1371/journal.pone.0014260.t003
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in salicylate and noise induced tinnitus
Manganese, an activity-dependent contrast agent, accumulates
in active neurons through, for example, voltage-gated calcium
channels. Increased neuronal activity results in increased cellular
manganese uptake. For a given region of interest then, differences
in manganese accumulation, measured non-invasively with MRI,
reflect differences in neuronal activity during the period of
manganese accumulation, before anesthesia and MR imaging
[55]. The use of MEMRI avoids a major drawback of doing
functional studies in MRI scanners for testing of central auditory
structures: an extremely noisy scanner environment. Since
manganese uptake is activity dependent and loss from the cell is
slow, neuronal activity in awake animals can thus be encoded
outside of the magnet with activity readout hours later.
In the present study, MRI images with high spatial resolution
were needed to analyze the relatively small regions in the auditory
brainstem. To this end, brain manganese levels were measured
using signal intensities from T1-weighted images. Normalization to
adjacent tissue is a common part of this approach, either to a
negative-control brain region [56,57] or to nearby muscle
[18,27,55,58]. The tissue used for normalization must be carefully
selected, as underlying group differences there may obscure or
over-emphasize group differences in regions of experimental
interest. The quality of normalization can be gauged by evaluating
negative-control regions, where no group differences are expected.
In the present work, negative findings at the anterior pituitary and
throughout the visual system – covering a broad range of
enhancement levels – are consistent with appropriate normaliza-
tion, as are the heterogeneous results for neighboring and
identically-normalized auditory regions (e.g. VCN vs. DCN).
Future work may benefit from T1 mapping of the brain [31] since
this will be sensitive to a broader range of tissue manganese
concentrations while being unaffected by receive-coil artifacts –
the primary motive for normalizing signal intensities in the present
study.
Recent studies have suggested that MEMRI can be used to
image the auditory brainstem [18,20,59]. For example, MEMRI
was used to identify tinnitus related activated brain regions ex vivo
[18]. Previous lower-resolution studies have utilized PET and MRI
to identify tinnitus associated brain regions that show changes in
neuronal activity [60], however the low resolution of these
techniques has prevented detailed identification of brain regions
involved. Further corroboration of the sensitivity of the MEMRI
for use in the auditory system is the interesting correlation of signal
intensity and brain regions in normal hearing controls. We found
Figure 7. Salicyate increases MEMRI measured signal intensity in the DCN but not the VCN. In the dorsal cochlear nucleus (DCN) a
significant increase in signal intensity was observed (A–B) in the salicylate treated group (242. 37612.08; p=0.02) when compared to controls
(210.2666.76), but no change was observed in the VCN (A, C). Noise exposure does not change MEMRI measured signal intensity in the DCN (209.
9065.22; p=0.02) or VCN (187. 4169.02; p=0.02) 48 hrs post noise exposure (A–C). Signal intensity is calculated as a percentage of nearby muscle.
Asterisk denotes significance, p#0.05; error bars equal StDev, C – control, S – salicylate, N - noise exposed In MRI panels white arrows indicate VCN,
green arrows indicate DCN, and blue arrows indicate ventricular space.
doi:10.1371/journal.pone.0014260.g007
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This fits well with other studies in which the VCN is reported to
have lower levels of spontaneous neuronal activity as assessed via
electrophysiology when compared to the DCN [61,62,63].
Following deafferentation, the DCN continues to show spontane-
ous activity while the VCN is quieted [64,65,66]. Our results
support these findings with the DCN exhibiting significantly more
manganese uptake than the VCN in normal hearing animals and
with only DCN showing changes in activity following tinnitus
induction.
MEMRI associated changes in neuronal activity within
auditory pathways occurred bilaterally. In the current
study, brains of animals with salicylate and noise induced
tinnitus-like percepts were compared during the early stages of
tinnitus onset. In the DCN and DCIC, there were no differences
observed in manganese uptake in the right and left sides. Since the
injections of salicylate were systemic, this result was not surprising.
However, in previous studies where a tone was presented directly
into a single ear, the changes in neuronal activity were lateralized,
[5,18,67] but when the IC was studied there was no difference in
Figure 8. Effects of salicyate and noise exposure on MEMRI measured signal intensity in the inferior colliculus after three days of
salicylate administration and 48 hrs post noise exposure. Signal intensity was compared across groups (A–D). In the salicylate group,
manganese accumulation was supernormal in the central nucleus of the inferior colliculus (B; CNIC; 174. 2063.60; p=0.03), as well as the dorsal
cortex (C; DCIC; 195. 2164.96; p=0.005) and external cortex (D; ECIC; 186. 5262.35; p=0.02) when compared to controls. In the noise exposed group,
only the DCIC had increased signal intensity (186. 3562.17; p=0.03). Asterisks denote significance, p#0.05; error bars equal StDev, C – control, S –
salicylate, N - noise exposed.
doi:10.1371/journal.pone.0014260.g008
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inserted into one ear for protection against profound hearing loss.
This ‘‘protection’’ resulted in an asymmetry in terms of hearing
loss in the right versus left ears possibly contributing to lateralized
tinnitus percepts. However our imaging studies suggest that the
tinnitus that was induced, at least during the early stages we tested,
was not hemisphere specific. We surmise that while the plug was
sufficient to preserve hearing well enough for animals to
successfully perform during ASR testing, the plug did not
prevent tinnitus-associated uptake of manganese in central
pathways associated with the plugged ear.
Specific tinnitus induction results in differential manga-
nese uptake. In the cochlear nucleus only the DCN showed an
increase in manganese uptake in our study, a result only observed in
the salicylate group. Salicylate has been shown to increase
spontaneous activity in the DCN using extracellular recording and
with imaging techniques. Using electrophysiology and a very similar
noise exposure to that of our study, another study has previously
shown increases inneuronal spontaneous activity in the DCN [8]. In
the current study we did not observe changes in the DCN of animals
from the noise group. Perhaps the observed differences can be
attributed to the time point we used for assessment. In that
electrophysiology study DCN activity was initially decreased
following exposure with increases in activity observed by five days.
We assessed changes in neuronal activity in the noise group two days
following the noise exposure. Assessing neuronal activity at a later
time point, when increased DCN activity is expected from noise-
induced tinnitus may yield significant differences from baseline. In a
previous tinnitus related MEMRI study, while no changes in
neuronal activity were observed in the DCN following noise there
were increases in manganese uptake in the PVCN [18]. This
discrepancy between that study and the current one may be due to
the difference in noise exposure. The previous study used a noise
exposure that resulted in a temporary threshold shift that had
returned to normal levels prior to manganese injection, while the
acoustic exposure in the current study results in a permanent
threshold shift and profound deafness. In the previous MEMRI
study, manganese was administered to animals showing
psychophysical evidence of tinnitus months after the sound
exposure. Therefore results from that study would include changes
in neuronal activity reflecting uptake due to chronic tinnitus and not
the early stages of tinnitus reported in the current study. More work
is now needed to resolve these issues.
In the inferior colliculus, both salicylate- and noise-induced
tinnitus resulted in significantly elevations in manganese uptake.
These results suggest an important role of IC, specifically DCIC,
involvement in tinnitus-related neuronal activity. Consistent with
this, tinnitus-associated changes in neuronal activity within the IC
have been reported following salicylate [60,67,68,69] and noise
alike [18,53,70,71,72].
In the present study, we found no significant activity differences
in the auditory cortex. This coincides with recent studies in the rat
using electrophysiology where changes in spike amplitude, but not
spontaneous activity were observed following salicylate and noise
[72]. However, in contrast to our results, PET studies in humans
and animals as well as autoradiography have suggested that
changes in auditory cortex activity occur in subjects with tinnitus.
One possible reason for this differential finding may be use of
guinea pigs in these earlier studies instead of rats, and/or use of a
different tracer (deoxyglucose), rather than manganese. Although
our results are based on linearization of the auditory cortices,
which provides a sensitive assessment of changes in individual
cortical layers [55], we did not find significant differences in
manganese uptake in the auditory cortex.
Conclusion
Our goal was to study in awake rats changes in neuronal activity
in tinnitus related brain regions that are common to different types
of tinnitus using two complementary approaches (ASR and
MEMRI). Since the current study focused on similarities and
differences emerging hours – days following tinnitus onset and the
mechanisms involving the maintenance of chronic may be very
different, in the future this approach can be expanded for use in
longitudinal studies and in evaluation of treatment efficacy
regardless of time following onset or method of induction. The
combination of ASR and MEMRI should prove to be quite a
powerful combination since MEMRI has high spatial resolution, is
not susceptible to scanner noise artifacts and both manganese
uptake and ASR can be measured repeatedly.
Methods
Ethics Statement
All procedures were approved by the Wayne State School of
Medicine ‘‘Laboratory Animal Care and Use Committee’’ (PHS
Animal Welfare Assurance number A3310-01) and conform to the
National Institutes of Health guidelines.
Subjects
Twenty-four male Sprague Dawley rats were obtained from
Charles River Laboratory. All rats were 2–3 months old weighing
250 g–270 g. The rats were individually housed and maintained at
25uC with a 12 hour light dark cycle. Three groups of animals
were studied. The control group consisted of animals in which
tinnitus was not induced (n=8) while in the other two groups
tinnitus was induced with either salicylate (n=6) or noise (n=6).
Limited testing was also performed in animals imaged without
manganese (n=2), animals tested with ASR without Mn
2+, but not
imaged (n=2), animals tested with ABR after manganese (n=2),
and ASR 4–10 days after noise exposure (n=2).
Auditory Brainstem Response (ABR) Testing
To determine the hearing thresholds for each group, ABR
measures were recorded before and after treatment, and after
MnCl2 administration. Animals were anesthetized with i.m.
injections of ketamine HCL (50 mg/kg) and xylazine (2 mg/kg)
and placed in a sound attenuating booth (Kinder Scientific Poway,
CA). Sub-dermal electrodes were inserted below the pinna
(reference electrode), on the top of the head (active electrode),
and below the contralateral pinna (ground electrode). A Beyer
speaker (Beyer, Germany) was placed into the external ear canal
and thresholds were obtained from tone bursts 5 ms in duration
for 340 trials for each of three frequencies (4, 12 and 20 kHz) up to
100 dB. Sound was generated and evoked potentials were
recorded amplified and filtered using Daqarta (Data AcQuisition
And Real-Time Analysis) digital signal processing software
package (v4.51, Interstellar Research, Michigan) and a Grass
preamplifier. Hearing thresholds were established by determining
the lowest intensity of a tone between 0–100 dB that elicits a
response at each frequency.
Control Protocol
Testing of the animals in the control group were interspersed
with testing of animals in the tinnitus groups. Each of the animals
had 2–3 days of baseline ASR’s recorded. Eight hours prior to
imaging, most control animals (N=8) were administered 66 mg
MnCl2?H20/kg (i.p.). This manganese dose and timing have been
shown adequate for functional brain imaging [55]. Two hours
prior to imaging, a post-MnCl2 ASR was recorded (Figure 2A). In
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verify that appropriate enhancement took place in all regions of
interest.
Salicylate Protocol
Baseline ASR tests were recorded in each animal (N=6) for two
to three days. Next, animals received a daily i.p. injection
(300 mg/kg) of sodium salicylate (Sigma Aldrich) in physiological
saline for three days. One hour following the second day of
salicylate administration a post treatment-ASR was recorded
followed by ABR testing for hearing thresholds. MnCl2 (Sigma,
Aldrich) was administered (i.p.; 66 mg MnCl2?H2O/kg) one hour
after the third salicylate injection, eight hours prior to imaging. A
post MnCl2 ASR was recorded two hours prior to imaging
(Figure 2B).
Noise Exposure Protocol
Baseline ASR tests were recorded in each animal (N=6) for two
to three days. For acoustic exposure, animals were first placed into
individual cages that were set on racks in a custom built noise
exposure booth. We have previously shown that the noise
exposure used here results in a permanent shift in hearing
threshold [54]. Since hearing is necessary for ASR testing, noise
exposure was attenuated for one ear: 30 minutes prior to noise
exposure, an ear plug was inserted into either the right or the left
ear canal (unilaterally, semi-randomly), and the auricle of the
plugged ear was folded and secured with a single stitch. Gauze was
taped over the stitched ear and a paper neck collar applied during
the noise exposure to prevent the animal from injuring the ear.
Noise was generated using DaqGen software (Daqarta, Interstellar
Research) channeled through 16 overhead speakers and Grass
preamplifiers controlled using an Apple computer. Animals were
exposed for 4 hours to a 10 kHz, 118 dB one-third octave band
tone. To determine the effects of noise exposure on both the
plugged and unplugged ears, ABRs and ASRs (using levels that
were detectable by the noise exposed animals – 75 and 90 dB)
were recorded 24 hrs following sound exposure. On the second
day post sound exposure, MnCl2 (66 mg MnCl2?H2O/kg) was
administered (i.p.) and imaging was conducted eight hours later,
with a post MnCl2 ASR recorded two hours prior to imaging
(Figure 2C).
Acoustic Startle Reflex (ASR) Testing
Based on previous studies, the acoustic startle reflex provides a
useful and reliable method for detecting salicylate and noise
induced tinnitus in rats [17,49]. All tests were performed in a noise
attenuation chamber with customized hardware and software
(Kinder Scientific, Poway, CA). Inside the chamber, animals were
placed inside a plexi-glass box resting on a piezoelectric force
transducer in a calibrated sound field. The adjustable ceiling of the
box was positioned above the animal to constrict excessive
movement. All ASR tests were conducted in the light. The ceiling
of the box has slits and sits 15 cm from the speaker located at the
top of the chamber. The output of the piezo transducer was
amplified, filtered, and the root mean square of the waveform
measured to estimate startle amplitude.
For each animal both pre-pulse inhibition (pASR) and gap
detection inhibition (gASR) of acoustic startle was conducted. First
pASR testing was performed, immediately followed by gASR
testing. Testing resulted in animals spending no more than one
hour per day in the testing chamber. pASR testing aids in the
interpretation of gASR data, providing a control for both hearing
loss and temporal processing dysfunction. In our paradigm, deficits
in gASR accompanied by normal pASR represent the presence of
tinnitus. For the pASR testing, pre-startle tones were presented at
4,8,12, 16, 20, and 24 kHz at levels of 45 and 60 dB in all groups
with the exception of the Noise Group: Since those animals
experienced hearing loss, levels of 75 and 90 dB were used in ASR
conducted post noise exposure. Each pre-startle tone was
presented for 20 ms, in a silent background 50 ms before the
sound off startle (120 dB broad band noise for 50 ms). For each
ASR test (pre-pulse - pASR or gap - gASR) a total of 10 trials were
run for each frequency at each intensity as well as in the sound off
startle condition for pASR and in both the sound off startle
condition and the sound in startle condition for gASR. The trials
were presented in a pseudo-randomized order, with inter-trial
intervals randomized between 1 and 6 s.
During gASR testing, a background tone of either, 4, 8, 12, 16,
20, or 24 kHz at 45 and 60 dB, (or 75 and 90 dB in post noise
exposed animals) was presented. A silent gap lasting 20 ms was
embedded in the tone 50 ms prior to the startle (120 dB wide band
noise). To determine a maximum startle response, a startle was
also elicited without any background tone (sound off startle). For
each frequency at each sound level, with 10 trials recorded for
each condition as with pASR.
MEMRI Image Acquisition
Eight hours post MnCl2 injection, animals were anesthetized
with urethane 3.9 ml/kg i.p. (36% solution, prepared fresh daily;
Aldrich) and promptly scanned. The timing between injection and
scanning was based on previous work showing that brain
manganese accumulation is adequate for functional imaging after
eight hours [55], as well as a study outlining a detailed time-course
for manganese enhancement in the mouse brain. In this approach,
MEMRI data report on brain activity between injection and
scanning – while animals are awake and freely-moving – with
anesthetic choice or scanning environment having little opportu-
nity to influence results [31]. To specifically check the effects of
urethane on manganese uptake, we have performed retinal
functional studies with MEMRI in the same animal before and
after death. We find no differences in retinal signal intensity (data
not shown). Thus, there is little reason to think that urethane
influences the manganese signal.
For the duration of the scan, each animal was placed on a
heated re-circulating water pad with a rectal thermometer to
monitor and maintain core body temperature. Scans were
performed on a 4.7 T Bruker Avance System using a whole body
transmit-only coil and a 3 cm internal diameter receive-only coil.
Individual images were acquired using a 3D RARE sequence
(repetition time [TR] 330 ms; echo time [TE] 6.9 ms, with a
RARE factor of 8, for an effective echo time of 28 ms; number
of acquisitions [NA] 4; matrix size 21662486120; field of
view [FOV] 2.8163.2263.12 cm
3; providing a resolution of
130 mm6130 mm6260 mm; 37 min/image). All animals were
alive when scanning was complete. As described previously [55],
we also scanned a ‘‘phantom’’ roughly the size of a rat’s head
(containing a 10:1 mixture of water and 0.67 mM MnCl2 in saline)
using the same parameters employed in animals for later modeling
of signal intensity changes as a function of distance from the
surface coil.
ASR Data Analysis
In the pASR paradigm results were calculated as the force of the
startle response following the pre-pulse preceded startle noise,
divided by the sound off (no background sound) startle multiplied
by 100. The results are therefore reported as the percent inhibition
of the sound off startle. For the gASR paradigm the data were
calculated in the same way except for each trial at each frequency
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in the presence of the background tone and in a silent background.
Data were analyzed using StatView for between group compar-
isons and SPSS software v 7.0 for repeated measures analysis of
variance (for within group comparisons) to determine significant
differences and post hoc comparisons to determine which means
contributed to the observed effects.
MEMRI Image Analysis
For these experiments increased manganese uptake was equated
to changes in ion regulation and increased neuronal activity.
Therefore the terms are used interchangeably throughout the text.
Image analysis proceeded, with slight modification, as detailed
elsewhere [55]. Briefly, the influence of surface coil position on
signal intensity was modeled, then corrected for within each image
using R scripts developed in-house (v.2.9.0; R Development Core
Team (2009); http://www.R-project.org). Next, average signal
intensity was measured from several manually-defined regions of
interest (ROIs) using MRIcro v.1.40, [73] with tracings of each
structure guided by the Paxinos and Watson (6
th Edition; 2007) rat
brain atlas including several sub-cortical auditory and non-
auditory regions: the medial geniculate nucleus (MGN), the
central nucleus, dorsal cortex, and external cortex of the inferior
colliculus (CNIC, DCIC and ECIC, respectively), the dorsal
cochlear nucleus (DCN) and ventral cochlear nucleus (VCN), the
paraflocculus (Pfloc), flocculus (Floc), amygdala (amyg), superior
colliculus (sup coll), and lateral geniculate nucleus (LGN).
Spherical ROIs were used to characterize the CNIC, MGN,
LGN, and sup coll (radius: 520 mm). Hand-drawn ROIs spanning
three consecutive coronal slices (each 260 mm thick) were used in
all other cases, except for the DCN: Owing to the small size of the
DCN, its ROI was drawn in two consecutive slices with the
broadest cross-sectional areas. Each anatomical region was
identified both by its broad contours, and proximity to prominent
adjacent structures: The contours of the paraflocculus and
cochlear nuclei, for instance, are clearly visible in several coronal
slices (e.g. Figure 7A), simplifying comparisons to the Paxinos and
Watson atlas and facilitating fine localization of the DCN and
VCN. Hand-drawn ROIs were placed at the rostrocaudal center
of each anatomical region, and drawn to occupy the entire coronal
profile of each region, excluding a buffer ($1 voxel wide,
depending on the ROI) at borders with neighboring brain regions
and tissues (e.g. choroid plexus). Appropriate ROI placement was
confirmed in parasagittal views, and the subject-to-subject
consistency of ROI placement was checked by at least two of
the authors.
Several cortical regions, both traditionally auditory – primary
auditory cortex (Au1) and dorsal zone of auditory cortex (AuD), and
regions not traditionally associated with auditory pathways -
temporal association area (TeA), lateral (V2L) and medial (V2M)
secondary visual cortex, and the monocular (V1M), binocular (V1B),
and rostral (V1) portions of the primary visual cortex – were
analyzed in a manner which preserves cortical layer-specific
information as previously described [55]. Briefly, high-order
polynomials were fit to the brain/no-brain border in coronal slices.
Lines perpendicular to the polynomials were automatically drawn,
and tilted in the rostrocaudal plane to be consistent with the brain
surface. Brainsignalintensities were evenly sampled alongtheselines
and organized as a linearized image of the cortex. Here, a linearized
version of the Paxinos and Watson atlas (6
th Edition; 2007) was used
to divide the linearized cortex into each ROI. Average profiles of
signal intensity as a function of cortical depth were then generated
for each ROI, and data at cortical depths corresponding to layers II
through IV used for between-subject comparisons.
For all functional comparisons of MEMRI data, brain signal
intensities were normalized to adjacent tissue, similar to the
approach used elsewhere [27,55,56]. Here, ROI signal intensities
(SI) were normalized adjacent muscle (normalized ROI SI=ROI
SI/muscle SI * 100). Muscle normalization can compensate for
any signal intensity gradients that remain after image processing,
as well as potential inter-individual differences in peripheral
MnCl2 uptake (e.g. liver sequestration). Normalization to a non-
auditory brain region, which might better-provide those benefits,
was also considered. However, association with tinnitus for most
brain regions remains unclear.
To check the quality of muscle normalization, additional
analyses were carried out at the anterior pituitary and adjacent
muscle. Because the anterior pituitary sits outside of the blood-
brain-barrier, it has been used in previous work to gauge non-
specific brain enhancement due to systemic increases in manga-
nese [74]. Here, anterior pituitary SI was analyzed using two
spherical ROIs (radius: 390 mm) placed to the left and right of
midline in coronal sections. To gauge whether muscle normali-
zation would reduce inter-individual variability in brain data, we
tested for a positive correlation between pre-normalization SIs for
the pituitary and the adjacent muscle (linear regression). To test
whether control and tinnitus groups experienced similar levels of
manganese uptake, we use one-way ANOVAs to compare pre-
normalization SIs for the pituitary and the adjacent muscle alike,
as well as normalized pituitary SIs.
Functional comparisons of MEMRI data from controls to each
tinnitus group were carried out by performing one-way ANOVAs
at each brain region. Significant ANOVA results were further
tested using post-hoc t-tests.
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